GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Clinical trial NCT03320642 · TERMINATED
Trial details
- NCT number
- NCT03320642
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-27
- Primary completion
- 2021-02-25
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.